Lower cochlear implant age threshold could improve speech skills -- NIH panel.
This article was originally published in The Gray Sheet
Executive Summary
LOWER COCHLEAR IMPLANT MINIMUM AGE THRESHOLD could substantially improve patients' speech and language skills, but evidence currently does not support use in children under two years old, a National Institutes of Health consensus panel concluded at a May 15-17 conference in Bethesda, Maryland. "We would guess as we are looking at the future that the [current] two-year cut-off may change, but right know we don't have enough evidence to say that it should," said panel Chairperson George Gates, University of Washington, at the panel's May 17 press conference.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.